
|Articles|January 1, 2008
Ideal length of androgen ablation for treatment of prostate cancer still debated
Although the observation is awaiting confirmation by more definitive data, it may be that in a select group of radiation-treated prostate cancer patients, 6 months of androgen ablation is as effective as a 3-year course of the adjuvant therapy in terms of cancer-specific survival.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA removes warning labels on hormone replacement therapy
2
BioProtect Balloon Spacer shows sustained quality-of-life benefits in long-term study
3
Theranostic therapies expand frontline use in prostate cancer
4
Data support safe reinduction of nadofaragene firadenovec in NMIBC
5




















